reserpine has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 8 (66.67) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fadayel, GM; Schmidt, CJ; Sullivan, CK; Taylor, VL | 1 |
| Ali, SF; Chang, LW; Slikker, W | 1 |
| Conarty, PF; Johnson, MP; Nichols, DE | 1 |
| Black, CK; Schmidt, CJ; Taylor, VL | 1 |
| Hekmatpanah, CR; McKenna, DJ; Peroutka, SJ | 1 |
| Gibb, JW; Hanson, GR; Johnson, M; Stone, DM | 1 |
| Rudnick, G; Schuldiner, S; Steiner-Mordoch, S; Wall, SC; Yelin, R | 1 |
| Fitzgerald, JL; Reid, JJ | 1 |
| Azmitia, EC; Gu, XF | 1 |
| Sabol, KE; Seiden, LS | 1 |
| Callahan, BT; Cord, BJ; McCann, UD; Ricaurte, GA; Yuan, J | 1 |
| Hasegawa, R; Ikeda, K; Karasawa, J; Tamura, K; Yamamoto, H; Yamamoto, T; Yasumoto, S | 1 |
1 review(s) available for reserpine and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Biogenic amines as biomarkers for neurotoxicity.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Biogenic Amines; Biomarkers; Female; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System; Reserpine | 1991 |
11 other study(ies) available for reserpine and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Animals; Brain Chemistry; Dialysis; Dopamine; Fluorobenzenes; Haloperidol; Homovanillic Acid; Male; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Rats; Rats, Sprague-Dawley; Reserpine; Serotonin Antagonists | 1992 |
[3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Designer Drugs; Dopamine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Uptake Inhibitors; Norepinephrine; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Regression Analysis; Reserpine; Serotonin; Synaptosomes | 1991 |
Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Biogenic Monoamines; Brain; Catecholamines; Hydroxydopamines; Indoles; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Oxidopamine; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Reserpine; Serotonin; Substantia Nigra; Tryptophan Hydroxylase | 1990 |
Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Cerebral Cortex; Corpus Striatum; Designer Drugs; Dopamine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Endings; Nervous System Diseases; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Reserpine; Serotonin | 1989 |
Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; alpha-Methyltyrosine; Amphetamines; Animals; Brain; Dopamine; Hydroxydopamines; Male; Methyltyrosines; N-Methyl-3,4-methylenedioxyamphetamine; Oxidation-Reduction; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Reserpine; Serotonin; Tryptophan Hydroxylase | 1988 |
Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Blood Platelets; Carrier Proteins; Cattle; Cell Membrane; Chromaffin Granules; Fenfluramine; Humans; In Vitro Techniques; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; p-Chloroamphetamine; Reserpine; Serotonin; Serotonin Plasma Membrane Transport Proteins | 1993 |
Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Biogenic Monoamines; Brain; Calcium; Electric Stimulation; Female; In Vitro Techniques; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Uptake Inhibitors; Pargyline; Rats; Rats, Sprague-Dawley; Reserpine | 1993 |
Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Stem; Carrier Proteins; Cells, Cultured; Clorgyline; Female; Fluoxetine; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neurons; Nimodipine; p-Chloroamphetamine; Pregnancy; Rats; Rats, Sprague-Dawley; Reserpine; Selegiline; Serotonin; Serotonin Plasma Membrane Transport Proteins | 1993 |
Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis.
Topics: Animals; Body Temperature; Dextroamphetamine; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Agents; Rats; Rats, Sprague-Dawley; Reserpine; Serotonin Agents | 1998 |
Effect of depleting vesicular and cytoplasmic dopamine on methylenedioxymethamphetamine neurotoxicity.
Topics: Adrenergic Uptake Inhibitors; alpha-Methyltyrosine; Animals; Corpus Striatum; Cytoplasm; Cytoplasmic Vesicles; Cytoprotection; Dopamine; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Hippocampus; Hypothermia; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Rats; Reserpine; Serotonin; Serotonin Agents; Temperature | 2002 |
Inhibitory effect of selective serotonin reuptake inhibitors on the vesicular monoamine transporter 2.
Topics: Animals; Dopamine; Fluoxetine; Fluvoxamine; Haloperidol; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Rats; Rats, Wistar; Reserpine; Selective Serotonin Reuptake Inhibitors; Synaptic Vesicles; Vesicular Monoamine Transport Proteins | 2009 |